Open Access Open Access  Restricted Access Subscription Access

Relative Bioavailability of Liposomal Vitamin C – ‘VitaLip-C’


Affiliations
1 Proprietor, Shreepad Shree Vallabh SSV Phytopharmaceuticals, Mumbai, India, India
2 Research Associate, Shreepad Shree Vallabh SSV Phytopharmaceuticals, Mumbai, India, India
 

   Subscribe/Renew Journal


Background: Vitamin C is a water-soluble vitamin and one of the most commonly used vitamins. With increasing vitamin C intake, the plasma steady state concentration reaches a maximal level of about 70–80 µM. However, from the available literature, it appears that a daily intake of about 200–400 mg of vitamin C ensures saturation of the blood in healthy individuals. Bioavailability can be increased by various methods, such as encapsulation, micronisation, etc. VitaLip-C is a liposomal form of vitamin C, which is shown to be clinically proven and evaluated by Transmission Electron Microscopy (TEM) for the presence of liposomes.


Keywords

Vitamin C, liposome, relative bioavailability, pharmacokinetics, VitaLip-C
Subscription Login to verify subscription
User
Notifications
Font Size


  • Trout DL. Vitamin C and cardiovascular risk factors. Am J Clin Nutr. 1991 Jan;53(1 Suppl):322S-325S. doi: 10.1093/ ajcn/53.1.322S.
  • Vojdani A, Ghoneum M. In vivo effect of ascorbic acid on enhancement of human natural killer cell activity. Nutr. Res.1993;13:753–764. doi: 10.1016/S0271-5317(05)80799-7.
  • Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr. 1991 Jan;53(1 Suppl):352S-355S. doi: 10.1093/ajcn/53.1.352S.
  • Hatch GE. Asthma, inhaled oxidants, and dietary antioxidants. Am J Clin Nutr. 1995 Mar;61(3 Suppl):625S-630S. doi: 10.1093/ajcn/61.3.625S.
  • Gund P. Progress in Molecular and Subcellular Biology. Three-dimensional pharmacophoric pattern searching.Berlin/Heidelberg, Germany: Springer; 1977. pp. 117–143.
  • Gaby SK, Bendich A, Singh V, Machlin LJ. Vitamin Intake and Health: A Scientific Review. Boca Raton, FL, USA: CRC Press; 1991. pp. 71–103.
  • Levine M, Asher A, Pollard H, Zinder O. Ascorbic acid and catecholamine secretion from cultured chromaffin cells. J Biol Chem. 1983 Nov 10;258(21):13111-5.
  • Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington (DC): National Academies Press (US); 2000. Food And Nutrition Board, Institute of Medicine-National Academy of Sciences Dietary Reference Intakes: Recommended Intakes For Individuals. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK225472/
  • Tveden-Nyborg P, Lykkesfeldt J. Does vitamin C deficiency increase lifestyle-associated vascular disease progression? Evidence based on experimental and clinical studies. Antioxid Redox Signal. 2013 Dec 10;19(17):2084-104. doi: 10.1089/ars.2013.5382.
  • Dachs GU, Munn DG, Carr AC, Vissers MC, Robinson BA.Consumption of vitamin C is below recommended daily intake in many cancer patients and healthy volunteers in Christchurch. N Z Med J. 2014 Mar 7;127(1390):73-6.
  • Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3704-9. doi: 10.1073/ pnas.93.8.3704.
  • Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9842-6. doi:10.1073/pnas.171318198.
  • Frei B, Birlouez-Aragon I, Lykkesfeldt J. Authors’ perspective: What is the optimum intake of vitamin C in humans? Crit Rev Food Sci Nutr. 2012;52(9):815-29.
  • Dound YA, Gaikwad Y. Effect of liposomal Vitamin C on immune function in children aged 4-12 Years. The Indian Practitioner. 2020;73(7):29-35.
  • CPCSEA Guidelines for Laboratory Animal Facility. Indian Journal of Pharmacology. 2003;35:257- 274.
  • Nasim K. Jugular Vein Cannulation in Rats – A Mini Review. Senra Academic Publishers, Burnaby, British Columbia 2009.3: 929-935.
  • Gabrielsson J and Weiner D. Pharmacokinetic and Pharmacodynamic data analysis: Concepts and Applications.3rd Edition. Swedish Pharmaceutical Press; 2000.
  • Cell Membranes. (2021, January 1). Tufts University & Harvard. Available from: https://bio.libretexts.org/@go/ page/3966.
  • Cevc G. Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy. J Control Release. 2012 Jun 10;160(2):135-46. doi: 10.1016/j.jconrel.2012.01.005.
  • Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532-55. doi: 10.1016/j.addr.2006.09.009.
  • Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr. 2005 Jan;81(1 Suppl):243S-255S. doi: 10.1093/ajcn/81.1.243S.
  • Bender D. Nutritional Biochemistry of the Vitamins (2nd ed.).Cambridge: Cambridge University Press; 2003. doi:10.1017/ CBO9780511615191.
  • Kraft JC, Freeling JP, Wang Z, Ho RJ. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci. 2014 Jan;103(1):2952. doi: 10.1002/jps.23773.
  • Rogers JA, Anderson KE. The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Syst. 1998;15(5):421-80.
  • Stano P, Bufali S, Pisano C, Bucci F, Barbarino M, Santaniello M, Carminati P, Luisi PL. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method. J Liposome Res. 2004;14(1-2):87-109. doi:10.1081/lpr-120039794.
  • Feng T, Wei Y, Lee RJ, Zhao L. Liposomal curcumin and its application in cancer. Int J Nanomedicine. 2017 Aug 21;12:6027-6044. doi: 10.2147/IJN.S132434.
  • Dound YA, Jayaraman R. Relative oral bioavailability study of liposomal Curcumin. The Indian Practitioner. 2020;73(10):21-25.
  • Łukawski M, Dałek P, Borowik T, Foryś A, Langner M, Witkiewicz W, Przybyło M. New oral liposomal vitamin C formulation: properties and bioavailability. J Liposome Res. 2020 Sep;30(3):227-234. doi: 10.1080/08982104.2019.1630642.
  • Davis JL, Paris HL, Beals JW, Binns SE, Giordano GR, Scalzo RL, Schweder MM, Blair E, Bell C. Liposomal-encapsulated ascorbic acid: influence on Vitamin C bioavailability and capacity to protect against ischemia-reperfusion Injury. Nutr Metab Insights. 2016 Jun 20;9:25-30. doi: 10.4137/NMI.S39764.
  • Stephen H, Hilary JR, Nicholas JM. Pharmacokinetics of oral vitamin C. Journal of Nutritional & Environmental Medicine. 2008;17(3):169-177. doi: 10.1080/1359084080230542s.

Abstract Views: 282

PDF Views: 176




  • Relative Bioavailability of Liposomal Vitamin C – ‘VitaLip-C’

Abstract Views: 282  |  PDF Views: 176

Authors

Yogesh Dound
Proprietor, Shreepad Shree Vallabh SSV Phytopharmaceuticals, Mumbai, India, India
Shivani Agawane
Research Associate, Shreepad Shree Vallabh SSV Phytopharmaceuticals, Mumbai, India, India
Khushbu Gupta
Research Associate, Shreepad Shree Vallabh SSV Phytopharmaceuticals, Mumbai, India, India

Abstract


Background: Vitamin C is a water-soluble vitamin and one of the most commonly used vitamins. With increasing vitamin C intake, the plasma steady state concentration reaches a maximal level of about 70–80 µM. However, from the available literature, it appears that a daily intake of about 200–400 mg of vitamin C ensures saturation of the blood in healthy individuals. Bioavailability can be increased by various methods, such as encapsulation, micronisation, etc. VitaLip-C is a liposomal form of vitamin C, which is shown to be clinically proven and evaluated by Transmission Electron Microscopy (TEM) for the presence of liposomes.


Keywords


Vitamin C, liposome, relative bioavailability, pharmacokinetics, VitaLip-C

References